113 related articles for article (PubMed ID: 9820173)
1. Lack of interleukin 6 (IL-6) and transforming growth factor alpha (TGF-alpha) expression in chromophobe renal cell carcinomas.
Chudek J; Schullerus D; Wilhelm M; Kovacs G
Br J Cancer; 1998 Nov; 78(9):1162-4. PubMed ID: 9820173
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
Hofmockel G; Riess S; Bassukas ID; Dämmrich J
Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
[TBL] [Abstract][Full Text] [Related]
4. Differential response to transforming growth factor (TGF)-alpha and fibroblast growth factor (FGF) in human renal cell carcinomas of the clear cell and papillary types.
Ramp U; Reinecke P; Gabbert HE; Gerharz CD
Eur J Cancer; 2000 May; 36(7):932-41. PubMed ID: 10785600
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of TGF-alpha, EGF and IL-6 in cultured renal tubular cells and renal cell carcinoma.
Aoyagi T; Takishima K; Hayakawa M; Nakamura H
Int J Urol; 1996 Sep; 3(5):392-6. PubMed ID: 8886918
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
[TBL] [Abstract][Full Text] [Related]
7. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
Türkeri LN; Erton ML; Cevik I; Akdaş A
Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
[TBL] [Abstract][Full Text] [Related]
9. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N
J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
Fujiwara Y; Higuchi K; Hamaguchi M; Takashima T; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Arakawa T
J Gastroenterol Hepatol; 2004 May; 19(5):521-7. PubMed ID: 15086595
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
Pan CC; Chen PC; Chiang H
Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
[TBL] [Abstract][Full Text] [Related]
14. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of kidney injury molecule-1 in renal epithelial neoplasms].
Dong YC; Wu B; Wang JD; Rao Q; Ma HH; Zhang RS; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):35-9. PubMed ID: 20388397
[TBL] [Abstract][Full Text] [Related]
18. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor alpha expression in normal human blood eosinophils: differential regulation by granulocyte-macrophage colony-stimulating factor and interleukin-3.
Walz TM; Nishikawa BK; Malm C; Briheim K; Wasteson A
Leukemia; 1994 Apr; 8(4):612-9. PubMed ID: 7512173
[TBL] [Abstract][Full Text] [Related]
20. Expression of the glucocorticoid receptor in renal cell neoplasms: an immunohistochemical and quantitative reverse transcriptase polymerase chain reaction study.
Yakirevich E; Matoso A; Sabo E; Wang LJ; Tavares R; Meitner P; Morris DJ; Pareek G; Delellis RA; Resnick MB
Hum Pathol; 2011 Nov; 42(11):1684-92. PubMed ID: 21531004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
